Evidence map›Paper›PMID 39089320›Full record

ArticlePloS one2024

Don't die like me: Which proteins are responsible for the selective neuronal vulnerability within the substantia nigra?

Simone Steinbach, Mariana Molina, Lea T Grinberg, Luisa Aring, Annika Guntermann, Katrin Marcus, Helmut Heinsen, Renata E Paraizo Leite, Caroline May

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Simone SteinbachMedizinisches Proteom-Center, Center of Protein Diagnostics (ProDi), Ruhr-Universität Bochum, Bochum, Germany.ORCID 0000-0003-0191-6515
Mariana MolinaPhysiopathology in Aging Lab/Brazilian Aging Brain Study Group-LIM22, University of São Paulo Medical School, São Paulo, Brazil.
Lea T GrinbergPhysiopathology in Aging Lab/Brazilian Aging Brain Study Group-LIM22, University of São Paulo Medical School, São Paulo, Brazil.ORCID 0000-0002-6809-0618
Luisa AringMedizinisches Proteom-Center, Center of Protein Diagnostics (ProDi), Ruhr-Universität Bochum, Bochum, Germany.
Annika GuntermannMedizinisches Proteom-Center, Center of Protein Diagnostics (ProDi), Ruhr-Universität Bochum, Bochum, Germany.ORCID 0000-0003-4688-5185
Katrin MarcusMedizinisches Proteom-Center, Center of Protein Diagnostics (ProDi), Ruhr-Universität Bochum, Bochum, Germany.
Helmut HeinsenInstitute of Forensic Pathology, Würzburg, Germany.
Renata E Paraizo LeitePhysiopathology in Aging Lab/Brazilian Aging Brain Study Group-LIM22, University of São Paulo Medical School, São Paulo, Brazil.
Caroline MayMedizinisches Proteom-Center, Center of Protein Diagnostics (ProDi), Ruhr-Universität Bochum, Bochum, Germany.ORCID 0000-0002-6532-5979

Funding

Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Serggio Carlo Lanata · 2019 to 2026
$36.9M
NIA NIH HHS P30 AG062422
6 · The paper itself

Abstract

A hallmark of Parkinson's disease is the specific degeneration of dopaminergic neurons in the substantia nigra pars compacta. Interestingly, not all of these neurons are affected to the same extent. Studies revealed that neurons located more ventrally within the substantia nigra pars compacta have a higher prevalence to degenerate than those located in the dorsal tier. The underlying reasons for this selective neuronal vulnerability are still unknown. The aim of the present study was to gain a better understanding of molecular differences between these two neuronal subpopulations that may explain the selective neuronal vulnerability within the human substantia nigra. For this purpose, the neurons from the ventral as well as dorsal tier of the substantia nigra were specifically isolated out of neuropathologically unremarkable human substantia nigra sections with laser microdissection. Following, their proteome was analyzed by data independent acquisition mass spectrometry. The samples were analysed donor-specifically and not pooled for this purpose. A total of 5,391 proteins were identified in the substantia nigra. Of these, 2,453 proteins could be quantified in 100% of the dorsal tier samples. 1,629 could be quantified in 100% of the ventral tier samples. Nine proteins were differentially regulated with a log2 value ≥0.5 and a Qvalue ≤0.05. Of these 7 were higher abundant in the dorsal tier and 2 higher in the ventral tier. These proteins are associated with the cytoskeleton, neuronal plasticity, or calcium homeostasis. With these findings a deeper understanding can be gained of the selective neuronal vulnerability within the substantia nigra and of protective mechanisms against neurodegeneration in specific neuronal subpopulations.

Indexed as

Substantia NigraAgedAged, 80 and overDopaminergic NeuronsFemaleHumansMaleMiddle AgedNeuronsParkinson DiseaseProteomeProteomicsProteome

Identifiers

PMID39089320
PMCPMC11290673

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.